Starbloom Capital
Signal active
Investment Firm
Overview
Starbloom Capital is a early-stage venture capital fund.
Highlights
Founded
2021
Industry
Employees
0
Investment
7
Lead Investment
2
Exits
undefined
Stages
Seed, Early Stage Venture
Investor Type
Family Investment Office, Venture Capital
Location
United States, North America
Contact Information
Social
Profile Resume
Starbloom Capital, established in 2021 and headquartered in United States, North America., specializes in Seed, Early Stage Venture investments across Biotechnology, Health Care, Medical, mHealth, Financial Services, Venture Capital, Incubators, Medical Device, Therapeutics, Health Diagnostics. Their recent investments include Orchid, Refactor, Conviction Capital, Cognito Therapeutics, Alzheimer's Drug Discovery Foundation. The highest investment round they participated in was $7.7B. Among their most notable exits are Orchid and Refactor. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.
Employees
N/A
Investment portfolio
Starbloom Capital has made 7 investments. Their most recent investment was on Mar 22, 2023, when Cognito Therapeutics raised $73.0M.
Starbloom Capital has made 2 diversity investments. Their most recent diversity investment was on Dec 05, 2023, when Orchid raised $12.0M.
investments
7
Diversity investments
2
Lead investments
2
Number of exits
undefined
Investments
7
| Annouced Date | Organization Name | Industry | Money Raised |
|---|---|---|---|
| Jan 31, 2023 | TBD Health | Health Care | 4.4M |
| Jan 31, 2023 | Rysk Finance | Finance | 1.4M |
| Mar 22, 2023 | Cognito Therapeutics | Biotechnology | 73.0M |
| Dec 05, 2023 | Orchid | Biotechnology | 12.0M |
Exits
0
Funding Timeline
Funding rounds
7
Investors
0
Funds
0
Funding Rounds
7
Starbloom Capital has raised 7 rounds. Their latest funding was raised on Dec 05, 2023 from a Seed Round - Orchid round.
| Annouced Date | Transaction Name | Number of Investors | Money Raised | Lead Investor |
|---|---|---|---|---|
| Jan 31, 2023 | Seed Round - TBD Health | - | 4.4M | - |
| Jan 31, 2023 | Pre Seed Round - Rysk Finance | - | 1.4M | - |
| Mar 22, 2023 | Series B - Cognito Therapeutics | - | 73.0M | - |
| Dec 05, 2023 | Seed Round - Orchid | - | 12.0M | - |
Investors
0
There is no funding round available on this profile
Fund raised
2
Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.
| Annouced Date | Fund Name | Money Raised |
|---|---|---|
| May 10, 2013 | OTPPLESS | 1.0M |
| May 11, 2013 | OTPPLESS | 1.0M |
Invest in industries
N/A
Recent Activity
There is no recent news or activity for this profile.